Ketoprofen Lysine Salt combines ketoprofen, a well-established nonsteroidal anti-inflammatory drug, with lysine, an amino acid often used to help improve solubility and absorption in pharmaceutical formulations. As producers, we observe the industry’s reliance on this salt form for its rapid dissolution in water, forming clear, stable solutions—a trait especially valuable when injectable or oral liquid forms need to be manufactured efficiently. The salt’s chemical formula is C16H14O3·C6H14N2O2, and it carries a molecular weight that’s the sum of both ketoprofen and lysine moieties, landing over 369 g/mol. Structurally, the addition of lysine to the carboxyl group of ketoprofen shifts the physiochemical properties, giving this compound its enhanced solubility and making it viable for more application routes than regular ketoprofen.
In our experience, Ketoprofen Lysine Salt appears as a solid, sometimes coarse powder, or as fine crystalline flakes, with a subtle pearlescent sheen. Rarely, small granules may form, but the product resists caking, which helps during storage and in automatic feeding systems. Density typically sits in the range of 1.2 – 1.3 g/cm³, based on bulk measurements, and flakes pour easily into reactors and blend tanks. Temperature and humidity during production control the habit of the crystals—higher humidity favors a slightly clumpier but still manageable mass, so monitored drying and air handling systems run continuously on our lines. Granulation, flake pressing, and micronization produce varied particle sizes matched to different formulation needs. We supply material from ultra-fine powder (for rapid dissolution in small volume liquids) to larger flakes designed for controlled, slow addition in bulk reactors. Each batch, tested on our in-house analytical equipment, shows consistent crystalline structure and purity, so manufacturers and formulation chemists can count on predictable performance from every shipment.
At our plant, specifications are enforced with strict quality control. Purity above 98% is maintained. Moisture content rarely exceeds 0.5%, since water can compromise storage life and change how the substance behaves during processing. Melting points typically register between 155°C and 160°C, which speaks to stability, especially during processes involving short high-heat exposures. Because we control impurities at the intermediate stages, the finished material does not degrade in standard pharmaceutical warehouse conditions. Packaging lines fill containers under nitrogen where required, and our staff checks for the presence of any foreign matter or dust that might have crept in during grinding or handling.
Ketoprofen Lysine Salt falls under the HS code 2916399090, grouped with other aromatic carboxylic acid derivatives. Customs clearance in major markets expects consistent labeling and COA—authorities look closely at incoming pharmaceutical intermediates. Trade teams at manufacturing-side need full transparency; documentation includes full chemical structure, safety data, and batch traceability. Our teams address audit requests from regulatory agencies, which have grown stricter, especially since industry recalls in the anti-inflammatory sector. Regulatory knowledge remains critical for both smooth export and reliable clearance by FDA, EMA, and associated organizations.
Experience in chemical manufacture shows no substitute for daily safety diligence. Ketoprofen Lysine Salt brings certain hazards: inhalation of dust may cause irritation, and long-term exposure at high concentrations can trigger mild sensitization symptoms among operators if controls are lax. Bulk manufacturers house powder transfer operations inside local exhaust systems. Material safety data and chemical labeling highlight these concerns to line workers; safety glasses, gloves, and fitted masks are standard-issue. Spills demand prompt cleanup due to slip hazards as well as potential airborne dust, so training runs focus on these simple but necessary steps. Fire risk sits low, since the salt does not ignite under regular operating conditions, but combustion can produce small amounts of irritating smoke, so firefighting protocols emphasize dry chemicals and controlled water spray. Waste from off-spec batches is sent to high-temperature incineration or managed as pharmaceutical hazardous waste. Flushing to sewer lines is not permitted, and the plant maintains sealed chemical drainage to isolate ketoprofen derivatives from municipal treatment works.
Reliable production tracks directly back to raw material integrity. We buy pharmaceutical-grade ketoprofen, which arrives as a fine white or off-white powder, and lysine as free base or hydrochloride, both known for their purity levels above 99%. These inputs demand tight relationship with trusted suppliers; fluctuations in global lysine markets or disruptions in API precursor manufacturing ripple downstream fast, affecting yield and finished product quality. Our procurement team checks COAs for each lot, audits vendor locations, and works with logistics to speed critical shipments when transport delays threaten continuity. Batch records document every shipment, so in the event of a quality concern, traceback to the original raw material is straightforward.
Listening to formulators and generic pharmaceutical customers drives our process adjustments. Demands for novel dosage forms, such as liquid ampoules, orally disintegrating tablets, or topical gels, pushed our R&D team to refine the particle size spectrum and explore the hydration behavior of Ketoprofen Lysine Salt. Some clients report better patient tolerability with salt forms instead of free acids, which tracks with studies showing less gastric irritation due to the increased solubility and dispersion. Manufacturers assembling gel and cream blends value the salt’s ease of suspension and incorporation, which supports uniform texture in final goods. Powder users sometimes struggle with sticking or bridging at humidities above 75%, so we offer advice on dehumidification and internally coat certain grades to further minimize compaction.
Plant managers have seen pressure mount for greener processes and smaller waste footprints, both from regulators and downstream brands concerned about environmental burden. The production of Ketoprofen Lysine Salt involves solvents in the condensation step, which raise concerns about VOC emissions and solvent waste. We installed closed-loop solvent recovery—over 90% of the solvent is recaptured, distilled, and reused in subsequent production batches. Scrubbers keep air emissions well under local and national thresholds; independent audits check compliance. Solids recovered from filtration are assessed for residual actives and repurposed wherever the regulations permit, primarily in non-pharmaceutical applications, or disposed of safely if reuse poses risk. Engineers review energy usage quarterly and retrofit heat exchangers and process cooling to shave points off kilowatt consumption, delivering benefits both to overheads and to carbon performance reported in ESG initiatives.
Producing Ketoprofen Lysine Salt at commercial scale opens windows into raw material dependability, chemistry know-how, batch-to-batch quality, safe chemical management, evolving downstream needs, and the need for clear regulatory compliance. Each batch moving from reactor to packaging area passes through hands and minds aware of these dependencies—process adjustments and open lines of communication with partners in research, quality assurance, and shipping keep the material flowing. Years spent making this product sharpen appreciation for both the strengths and persistent bottlenecks seen in pharmaceutical chemical manufacture, especially when end users, regulators, and patients expect not just a viable active ingredient but a consistently safe and high-performing input to their own complex processes.
